Japanese encephalitis (JE)
Japanese encephalitis (JE), the leading cause of viral encephalitis in Asia, causes an estimated 30,000 to 50,000 cases and 10,000 to 15,000 deaths each year, mostly among children under 15 years of age. There is no specific treatment for JE. Vaccination is the single most important measure for controlling the disease.
More about JE | View resources on JE
Key resources
World Health Organization Position Paper on Japanese Encephalitis Vaccines (2006)
An article from the WHO Weekly Epidemiological Record on recommendations on JE disease and the use of vaccines.
Meeting Minutes: Third Biregional Meeting on Control of Japanese Encephalitis (2007)
A
report on JE surveillance, diagnostics, and immunization programs.
Current Use and Development of Vaccines for Japanese Encephalitis (2008)
A literature review analyzing the use of current JE vaccines and development of alternative vaccine candidates.
Featured PATH resources
Protecting India's Children from Japanese Encephalitis (2007)
A
fact sheet on the partnerships and commitments that helped the Government of India introduce a landmark strategy to vaccinate children at highest risk.
JE Vaccines at a Glance (2008)
A
side-by-side comparison of internationally available JE vaccines, including information on dosage, cost, and supply.
PATH's Japanese Encephalitis Project (2007)
A fact sheet on PATH's work on Japanese encephalitis, including information on the project team and its partners.
